Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Intervalo de año de publicación
1.
Rev. panam. salud pública ; 36(1): 44-49, Jul. 2014. ilus
Artículo en Inglés | LILACS | ID: lil-721542

RESUMEN

The regional Latin American and Caribbean (LAC) Neonatal Alliance and national neonatal alliances in Bolivia, El Salvador, and Peru were studied through in-depth interviews and a review of publications. Findings were analyzed to distill successful strategies, structures, and tools for improving neonatal health by working through alliances that can be replicated at the regional or national level. The studies found the following factors were the most critical for successful outcomes from alliance work: inclusion of the Ministry of Health as a leader or primary stakeholder; a committed, diverse, technically expert, and horizontal membership; the presence of champions for neonatal health at the national level; development of a shared work plan based on feasible objectives; the use of shared financing mechanisms; the use of informal and dynamic organizational structures; and a commitment to scientific evidence-based programming. The relationship between the regional and national alliances was found to be mutually beneficial.


Se estudiaron la Alianza de Salud Neonatal para América Latina y el Caribe a escala regional, y las alianzas nacionales de salud neonatal de Bolivia, El Salvador y Perú, mediante entrevistas exhaustivas y un análisis de las publicaciones. Se analizaron los resultados para extraer las estrategias, las estructuras y las herramientas eficaces para mejorar la salud neonatal trabajando mediante alianzas que puedan repetirse a escala regional o nacional. Los estudios descubrieron que los factores más decisivos para obtener resultados exitosos del trabajo mediante alianzas fueron los siguientes: la inclusión de los ministerios de salud como líderes o interesados directos principales; una afiliación comprometida, diversa, técnicamente experta y horizontal; la presencia de promotores de la salud neonatal a escala nacional; la formulación de un plan de trabajo compartido basado en objetivos factibles; la utilización de mecanismos de financiamiento compartido; el uso de estructuras organizativas informales y dinámicas; y un compromiso con la programación científica basada en datos probatorios. Se observó que la relación entre las alianzas regionales y nacionales resultaba mutuamente beneficiosa.


Asunto(s)
Humanos , Recién Nacido , Servicios de Salud del Niño/organización & administración , Servicios de Salud del Niño/normas , Promoción de la Salud , Salud del Lactante , Región del Caribe , América Latina
3.
Buenos Aires; IECS; dec. 2013. graf, tab.(Technical report IECS, 12).
Monografía en Inglés | BRISA/RedTESA | ID: biblio-876819

RESUMEN

BACKGROUND: Postpartum hemorrhage (PPH) is a leading cause of maternal death. Despite strong evidence showing the efficacy of oxytocin in preventing PPH, use of the drug for this purpose remains suboptimal. The Uniject injection system prefilled with oxytocin (OiU) has the potential advantage, due to its ease of use, to increase oxytocin coverage rates (OCR). OBJECTIVES: To evaluate the cost-effectiveness of OiU in Latin America and the Caribbean (LAC). METHODS: An epidemiological model was built to estimate the impact of replacing oxytocin in ampoules with OiU on the incidence of PPH, quality-adjusted life years (QALYs), and costs, from a health care perspective. A systematic search for data on epidemiology and cost studies was undertaken. A consensus panel among LAC experts was performed to quantify the expected increase in OCR as a consequence of making OiU available. Deterministic and probabilistic sensitivity analyses were performed. RESULTS In the threshold analysis the minimum required increment in the OCR to make OiU a costeffective strategy ranged from 1.3% in Suriname to 15.8% in Haiti. In more than 60% of the countries, the required increment was below 5%. OiU could prevent more than 40,000 PPH episodes annually in LAC. In 27% of the countries, OiU was found to be cost saving. In the remaining 22 countries, OiU was associated with a net cost increment (0.005 to 0.847 2013 US dollars per delivery). OiU strategy ranged from being dominant to having an incremental costeffectiveness ratio (ICER) of US$ 8,990 per QALY gained. In the great majority of countries these ICERs were below one GDP per capita. CONCLUSIONS OiU was cost-saving or very cost-effective in almost all countries. Even if countries can achieve only small increases in OCR by incorporating OiU, this strategy could be considered an efficient use of resources. These results were robust in the sensitivity analysis under a wide range of assumptions and scenarios. (AU)


Asunto(s)
Humanos , Femenino , Embarazo , Análisis Costo-Beneficio/economía , Oxitocina/análisis , Hemorragia Posparto/prevención & control , Región del Caribe , Inyecciones , América Latina , Evaluación de la Tecnología Biomédica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA